Triple-negative breast cancer: treatment challenges and solutionsGuy Jérusalem, Laurence Lousberg, Joëlle Collignon et al.|Breast Cancer Targets and Therapy|2016Cited by 382
Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategiesLaurence Lousberg, Guy Jérusalem, Joëlle Collignon|Therapeutic Advances in Medical Oncology|2016Cited by 40
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast CancerLaurence Lousberg, Guy Jérusalem|Breast Cancer Basic and Clinical Research|2016Cited by 12
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Laurence Lousberg et al.|BMC Cancer|2025Cited by 7
Appendiceal neuroendrocrine neoplasmsLaurence Lousberg, Olivier Detry, Joëlle Collignon|Current Opinion in Gastroenterology|2019Cited by 4